Phaliwong Paweena, Pariyawateekul Piyawan, Khuakoonratt Nathaya, Sirichai Worrawan, Bhamarapravatana Kornkarn, Suwannarurk Komsun
Gynecologic Oncology Unit, Department of Obstetrics and Gynecology, Bhumibol Adulyadej Hospital, Bangkok, Thailand. Email:
Asian Pac J Cancer Prev. 2018 May 26;19(5):1331-1336. doi: 10.22034/APJCP.2018.19.5.1331.
Objectives: To determine the prevalence of abnormal Papanicolaou (Pap) smear, cervical intraepithelial neoplasia (CIN) 2 or higher and cancer between conventional Pap smear (CPP) and liquid based Pap smear (LBP). Methods: This retrospective study was conducted at Bhumibol Adulyadej Hospital, Bangkok, Thailand between January 2011 and December 2016. Data was collected from medical records of participants who attended for cervical cancer screening test. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy for detecting CIN 2 or higher were evaluated by using the most severity of histopathology reports. Results: A total of 28,564 cases were recruited. Prevalence of abnormal Pap smear from CPP and LBP were 4.8 % (1,092/22,552) and 5.7 % (345/6,012), respectively. Percentage of unsatisfactory smears in CPP (52.3%) was higher than LBP (40.5%). From CPP and LBP, cervical cancer percentages were 0.2 and 0.1, respectively. Sensitivity, specificity, PPV, NPV and accuracy of CPP and LBP for detection cancer were 42.5 vs 26.1%, 99.9 vs 100.0%, 69.8vs 75.0%, 99.7 vs 100.0 % and 99.7 vs 99.7%, respectively. Conclusion: Prevalence of abnormal cervical cytology and cancer from CPP and LBP were 4.8/0.2 and 5.7/0.1 percent, respectively. Unsatisfactory smear of LBP was less than CPP. Sensitivity, specificity, PPV, NPV and accuracy of CPP and LBP for detection CIN 2 or higher and cancer were comparable.
确定传统巴氏涂片(CPP)和液基巴氏涂片(LBP)中异常巴氏涂片、宫颈上皮内瘤变(CIN)2级或更高级别以及癌症的患病率。方法:这项回顾性研究于2011年1月至2016年12月在泰国曼谷的普密蓬·阿杜德医院进行。数据收集自参加宫颈癌筛查检测的参与者的医疗记录。使用组织病理学报告的最严重程度评估检测CIN 2级或更高级别病变的敏感性、特异性、阳性预测值(PPV)、阴性预测值(NPV)和准确性。结果:共招募了28564例病例。CPP和LBP的异常巴氏涂片患病率分别为4.8%(1092/22552)和5.7%(345/6012)。CPP中不满意涂片的百分比(52.3%)高于LBP(40.5%)。CPP和LBP的宫颈癌百分比分别为0.2和0.1。CPP和LBP检测癌症的敏感性、特异性、PPV、NPV和准确性分别为42.5%对26.1%、99.9%对100.0%、69.8%对75.0%、99.7%对100.0%和99.7%对99.7%。结论:CPP和LBP的异常宫颈细胞学和癌症患病率分别为4.8/0.2%和5.7/0.1%。LBP的不满意涂片少于CPP。CPP和LBP检测CIN 2级或更高级别病变以及癌症的敏感性、特异性、PPV、NPV和准确性相当。